MRI guidance during breast cancer radiation treatment
Part of Cancer, Skin clinical trials.
This trial studies using MRI images to help plan and guide radiation therapy after breast-conserving surgery. It may help doctors target the right area more accurately while keeping treatment standard and safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can do daily activities at a moderate level (ECOG 0–2) or you have a general health score of 60% or higher (Karnofsky).
- You can understand the study and agree to sign written consent.
- You have confirmed breast cancer (invasive or noninvasive/dcis) from pathology testing.
- Your doctor says you need radiation after lumpectomy (breast-conserving surgery) as part of standard care.
- You must be female.
- You can safely have an MRI based on an MRI safety checklist, and your tumor area can be seen on planning CT and MRI.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a breast MRI scan to look at suspicious areas in the breast. It may help doctors better tell which breast changes need closer follow-up like a biopsy.
This study uses breast MRI scans to see whether neoadjuvant (before-surgery) chemotherapy is working. If you qualify, you’ll have MRI scans to help doctors understand how your breast cancer responds to standard treatment.
This study tests a faster, targeted type of radiation for early breast cancer, using real-time MRI to help plan and guide treatment. It may help deliver the same cancer-fighting effect while limiting radiation to the rest of the breast.
This trial checks the brain using MRI in people with breast cancer that has spread outside the breast or can’t be fully removed. The goal is to screen for brain involvement and see how MRI findings fit with treatment timing, when it’s safe to do so.
This study tests advanced MRI imaging techniques to better diagnose breast cancer and evaluate treatment response. If you have a suspicious breast lesion, this trial may help doctors see it more clearly before biopsy or surgery.
This study tests selected treatment decisions for women with early-stage breast cancer that has certain lab test results. It may help researchers better match care using MRI and tumor marker information.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.